|IPA is hosting a tour of its world class therapeutic antibodies lab in Victoria on Wed August 14 for shareholders. The event will be hosted by CEO Dr Jennifer Bath. It starts at 2:00 pm followed by a social event at 4:00. More information and RSVP details here:|
A six minute YouTube interview:
IPA is in the doghouse, I get it. I was pissed off at it too after buying into the $1 pp. I sold it all but I've re-entered because operationally good things ARE happening.
New IPA sub Talem is cool because IPA isn't going to be just a fee for services contractor (CRO). Talem's role as I understand it will be to collaborate with pharmaceutical and biotechs, and take some form of ownership interest (royalties?) in discovery projects. I'm hearing there is a lot of interest flowing into the co. It makes sense. A lousy analogy is like IPA providing the shovels to miners; except they are the ones that know how to use the shovels and it ain't anything like shovels.
There's been a lot of news recently on artificial intelligence. I know that IPA has been working on AI for some time. I don't know much more than that. They won't be expecting this, they may not want to say much; but It'll be an opportunity to see sneak in some questions on AI, anyway.